ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IBT International Biotechnology Trust Plc

618.00
0.00 (0.00%)
Last Updated: 09:22:38
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
International Biotechnology Trust Plc LSE:IBT London Ordinary Share GB0004559349 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 618.00 608.00 624.00 9,368 09:22:38
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Trust,ex Ed,religious,charty 12.06M 6.81M 0.1733 35.66 242.99M

Intl. Biotechnology Trust PLC Issue of Equity (6435A)

02/06/2021 5:51pm

UK Regulatory


International Biotechnol... (LSE:IBT)
Historical Stock Chart


From Apr 2021 to Apr 2024

Click Here for more International Biotechnol... Charts.

TIDMIBT

RNS Number : 6435A

Intl. Biotechnology Trust PLC

02 June 2021

2 June 2021

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

("IBT" or the "Company")

Issue of Shares

The Company announces that it has today issued the remaining 43,846 Ordinary shares from treasury at a price of 718.45 pence per Ordinary share and at a premium to the prevailing net asset value.

In addition, the Company also issued 11,154 Ordinary shares of 25 pence each ("Ordinary Shares") pursuant to its block listing facility. The Ordinary Shares were issued at a price of 718.45 pence per Ordinary Share and at a premium to the prevailing net asset value.

Following the issue of the Ordinary Shares, the Company's issued share capital will comprise 41,353,817 Ordinary Shares and this is the total number of Ordinary Shares with voting rights in the Company.

This figure ( 41,353,817 ) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules

For further information contact:

Company Secretary - Link Company Matters

   Claire Jackson             +44 (0)7821 843993 

LEI: 213800N1QUJ744P76D11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEQLLFBFQLEBBB

(END) Dow Jones Newswires

June 02, 2021 12:51 ET (16:51 GMT)

1 Year International Biotechnol... Chart

1 Year International Biotechnol... Chart

1 Month International Biotechnol... Chart

1 Month International Biotechnol... Chart

Your Recent History

Delayed Upgrade Clock